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Given the presence of milder nerve abnormalities of the 
right lower limb in addition to the patient’s left sided 
lower limb weakness, the cause is likely multifactorial 
and temporally related to his cancer treatments. 
 
Persistent or worsening neuropathy features may 
appear in patients who received vincristine despite 
termination of treatment.  A review by Seretny et. al. 
found that 68.1% of patients experience chemotherapy 
induced peripheral neuropathy one month after 
chemotherapy, and 30% continue to experience 
neuropathy six or more months after treatment.  The 
pattern of CIPN is typically predominantly a sensory 
neuropathy, but may be accompanied by motor 
changes, as seen in this patient, or even autonomic 
features. 
 
The left worse than right pattern could suggest 
radiation induced neuropathy, but no myokymic 
potentials were seen. Myokymic potentials are 
common in radiation induced neuropathy, although 
their absence does not rule this out. 
  
Management: Treatment included physical therapy, 
gabapentin, and an ankle foot orthosis. 
  
Outcome: Fourteen months after completing radiation 
and seven months after completing chemotherapy, the 
patient’s symptoms are markedly improved. 
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Case: 24-year-old male with worsening left foot 
neuropathy following chemotherapy and radiation 
treatment for sarcoma in the left thigh. 
Background: He had previously undergone local 
resection of a 12cm x 8cm x14.5cm 
rhabdomyosarcoma in the left vastus lateralis. He was 
then treated with vincristine for 40 weeks and radiation 
to the left lateral thigh with a maximum dose of 50.4 Gy.  
The sciatic nerve was outside the target area and 
received a lower dose.  While undergoing 
chemotherapy, the patient experienced bilateral 
dysesthesias in his fingertips and feet. He had no 
history of neuropathy prior to treatment. After 
chemotherapy was completed, these symptoms 
subsided in all extremities except for the left foot, which 
developed atraumatic plantar flexion and dorsiflexion 
weakness, great toe extensor and flexor weakness, and 
decreased sensation in the distal great toe to the 
metatarsal. 
Exam: Sensation was decreased in the left distal great 
toe to the metatarsal, but was otherwise intact in the 
lower limbs.  Distal pulses were intact. Left extensor 
hallucis longus strength was 3/5, left extensor digitorum 
brevis was 3/5, left toe flexion was 3/5, ankle 
dorsiflexion was 4/5, and ankle plantar flexion was    
4+/5.  Strength was otherwise intact in the lower limbs. 
Neuro Diagnostics: Electromyography and needle 
conduction studies demonstrated left worse than right 
polyneuropathy mainly affecting the tibial and peroneal 
motor nerves.  There was no clear evidence of a single 
nerve compressive lesion. (Figure 1) 
Imaging: Repeat scans of the left thigh showed no new 
lesion. (Figure 2) 
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DISCUSSION CASE DESCRIPTION 
Figure 1: Motor nerve conduction and EMG studies 
Figure 2: MRI with of left thigh prior to surgical resection (left) 
and repeat MRI (right) at time of onset of neuropathy symptoms 
one year post-op.  
CONCLUSIONS 
Neuropathy after treatment in sarcoma patients may be 
multifactorial. Imaging may be necessary to rule out 
recurrence. Establishing both the chronology of 
complaints and cancer treatments is important to 
determine the most likely etiology. 
